Kintara Therapeutics (KTRA) Q2 2023 Earnings

Sep 18Confirmed
Nov 2022
Q4 2022
Q1 2023
Q2 2023
-3.5
-2.39
-1.29
-0.18

Details

Expected EPS
-1.05
Actual EPS
-1.95
Surprise EPS
-0.9
Surprise Percent
-85.71%

Description

⁨Kintara Therapeutics⁩ (⁦KTRA⁩) has reported earnings of ⁦-1.95⁩ per share for ⁦Q2 2023⁩.

0 Comments

Share your thoughts